Treating invasive group a streptococcal infections

Paediatrics and Child Health (United Kingdom)

Volumn 24, Issue 6, 2014, Pages 242-247

  Lees, Emily A ^a   Carrol, Enitan D ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Emm gene; Epidemiology; IVIG; Streptococcal vaccines; Streptococcus pyogenes; Toxic shock

Indexed keywords

AZITHROMYCIN; BACTERIAL VACCINE; CEFOTAXIME; CLINDAMYCIN; HYPERTENSIVE FACTOR; IMMUNOGLOBULIN; M PROTEIN VACCINE; MACROLIDE; N TERMINUS PROTEIN VACCINE; NON M PROTEIN VACCINE; PENICILLIN G; PENICILLIN V; SUPERANTIGEN; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL TRANSMISSION; DEBRIDEMENT; DISEASE SEVERITY; FLUID RESUSCITATION; GROUP A STREPTOCOCCAL INFECTION; HUMAN; INVASIVE GROUP A STREPTOCOCCAL INFECTION; MORBIDITY; MORTALITY; NECROTIZING FASCIITIS; PATHOGENESIS; PROPHYLAXIS; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; STREPTOCOCCAL TOXIC SHOCK SYNDROME; SURGICAL APPROACH; TOXIC SHOCK SYNDROME; VACCINATION;

EID: 84901657000     PISSN: 17517222     EISSN: 1878206X     Source Type: Journal    
DOI: 10.1016/j.paed.2014.01.001     Document Type: Review

References (12)

1. Bogdan L., Darenberg J., Neal S., et al. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. JClin Microbiol 2009, 47:1155-1165.
2. Filleron A., Jeziorski E., Michon A., Rodiere A., Marchandin H. Current insights in invasive group A streptococcal infections in paediatrics. Eur J Paediatr 2012, 171:1589-1598.
3. Laupland K.B., Davies H.D., Low D.E., Schwartz B., Green K., McGeer A. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Paediatrics 2000, 105:E60.
4. Lesko S., O'Brien K.L., Schwartz B., Vezina R., Mitchell A.A. Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella. Paediatrics 2001, 107:1108-1115.
5. Lynskey N., Lawrenson R., Sriskandan S. New understandings in Streptococcus pyogenes. Curr Opin Infect Dis 2011, 24:196-202.
6. Public Health England Interim UK guidelines for management of close community contacts of invasive Group A Streptococcal disease (iGAS) 19th March 2008, Available at:. http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/StreptococciGroupA/.
7. Ralph A., Carapetis J. Group A streptococcal diseases and their global burden. Host-pathogen interactions in streptococcal diseases 2013, 1-27. Springer-Verlag, Berlin. K. Aktories, G. Singh Chhatwal (Eds.).
8. Shulman S., Tanz R., Dale J. Seven-year surveillance of North American pediatric group A streptococcal pharyngitis isolates. Clin Infect Dis 2009, 49:78-84.
9. Smith A., Lamagni T., Oliver I., Efstratiou A., George R., Stuart J. Invasive group A streptococcal disease: should close contacts routinely receive antibiotic prophylaxis?. Lancet Infect Dis 2005, 5:494-500.
10. Steer A., Dale J., Carapetis J. Progress toward a global group A streptococcal vaccine. Paediatr Infect Dis J 2013, 32:180-182.
11. Timmis A., Parkins K., Kustos I., Riordan F.A., Efstratiou A., Carrol E.D. Invasive group A streptococcal infections in children presenting to a paediatric intensive care unit in the North West of England. JInfect 2010, 60:183-186.
12. Wang S.M., Lu I.H., Lin Y.L., et al. The severity of Streptococcus pyogenes infections in children is significantly associated with plasma levels of inflammatory cytokines. Diagn Microbiol Infect Dis 2008, 61:165-169.